Ms Marble Nasasira
| Call | Disease Outbreak and Epidemic Response (EPI Fellows) |
| Programme | EDCTP2 |
| Start Date | 2021-09-01 |
| End Date | 2024-08-31 |
| Project Code | CSA2020E-3126 |
| Status | Active |
Title
Consortium for Development of Sustainable Research Based Fellowship Training on Infectious Disease Epidemiology and Biostatistics in Africa (IDEA)
Host Organisation
| Institution | Country |
|---|---|
Current Organisation
Child and family Foundation Uganda
Current Job Title
Research and Grants Officer
Education
| Institution | Degree | Year |
|---|---|---|
| Mbarara University of Science and Technology, Uganda | Mbarara University of Science and Technology | 2022-08-11 |
| Makerere University, Uganda | Master of Science in Clinical Epidemiology and Biostatistics | 2022-05-23 |
Publications
Projects
Fellow:
Marble Nasasira
Collaborators:
| Name | Country | Institution |
|---|---|---|
| Drug Resistant Tuberculosis patients | Uganda | Mulago Hospital |
Objectives:
We determined the incidence and factors associated with adverse drug
events among patients receiving DR-TB treatment at Mulago Hospital in Uganda.
Sites:
Mulago National Referral Hospital
Study Design:
Retrospective cohort study
Subjects:
Drug resistant Tuberculosis patients
Outcomes:
Adverse drug events
Start Date:
2021-08-01
End Date:
2022-12-31
Fellow:
Marble Nasasira
Collaborators:
| Name | Country | Institution |
|---|---|---|
| Drug Resistant Tuberculosis patients | Uganda | Makerere University |
Objectives:
1) What is the incidence of QTC prolongation among patients receiving drug resistant tuberculosis treatment in Uganda.
2) What are the predictors of QTC prolongation among patients receiving drug resistant tuberculosis treatment in Uganda.
Sites:
Sixteen hospitals managing Drug Resistant Tuberculosis
Study Design:
Retrospective cohort study
Subjects:
Drug resistant Tuberculosis patients
Outcomes:
• The findings will be used by national TB program to plan the ECG requirements in the DR-TB health facilities in the country.
• The findings will be used as beach mark for timely ECG monitoring.
• Patients will be educated about their perception of risks associated with medicines, to look out for symptoms of cardiac toxicity such that they can be timely reported. This will enhance the clinical care of patients thereby leading to an improved their perception of risks associated with medicines.
Start Date:
2022-11-28
End Date:
2023-10-31